Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
Yahoo
Wed, 03/13/13 - 12:19 pm
Tags:
Receptos, anti-interleukin-13, AbbVie
Don't Blame AbbVie for Humira's Success
Motley Fool
Tue, 03/12/13 - 11:36 am
Tags:
AbbVie, Humira
Some Experts Defend Niacin For Heart Disease After Failed Study
Forbes
Tue, 03/12/13 - 11:33 am
Tags:
niacin, Merck, Niaspan, AbbVie
AbbVie seeks to stop EU agency releasing drug data
Reuters
Mon, 03/11/13 - 10:46 am
Tags:
AbbVie, drug data, EMA, Europe
Amgen And The Biosimilar Threat: Lessons From Affymax
Seeking Alpha
Fri, 03/8/13 - 11:12 am
Tags:
biosimilars, Amgen, Affymax, AbbVie, Biogen Idec, Celgene, Fresenius, Merck, Gilead
AbbVie's Humira Success, Strong Pipeline Make It A Buy
Seeking Alpha
Tue, 03/5/13 - 10:34 am
Tags:
Humira, AbbVie, Abbott Labs
Do These Pipeline Drugs Hold the Key to AbbVie's Future?
Motley Fool
Sun, 03/3/13 - 11:32 am
Tags:
AbbVie, GLPG0634, BT-061, rheumatoid arthritis, psoriasis
Do These Pipeline Drugs Hold the Key to AbbVie's Future?
Motley Fool
Fri, 03/1/13 - 11:10 am
Tags:
AbbVie, BT-061, Humira, GLPG0634
Is AbbVie Wasting Your Money?
Motley Fool
Sun, 02/24/13 - 02:23 pm
Tags:
AbbVie
Aches And Pains Shouldn't Obscure Achillion's Potential
Seeking Alpha
Fri, 02/22/13 - 10:38 am
Tags:
Achillion, AbbVie, JNJ, Gilead, Bristol-Myers Squibb
Can JAK Inhibitors Challenge Biologics?
Motley Fool
Wed, 02/20/13 - 05:15 pm
Tags:
JAK inhibitors, Remicade, JNJ, Enbrel, Stelara, Amgen, Humira, AbbVie
4 Healthcare Stock Stories Starting Off the Short Week
Wall St. Cheat Sheet
Tue, 02/19/13 - 09:58 am
Tags:
Novartis, AbbVie, St. Jude Medical, Amicus Therapeutics
Merck's Weakest Blockbuster?
Motley Fool
Tue, 02/19/13 - 09:41 am
Tags:
Merck, Remicade, rheumatoid arthritis, AbbVie, Humira
Does the Arthritis Market Have Growing Pains?
Motley Fool
Mon, 02/18/13 - 11:53 am
Tags:
rheumatoid arthritis, TNF blockers, Humira, AbbVie, Pfizer, Xeljanz
Does the Arthritis Market Have Growing Pains?
Motley Fool
Sun, 02/17/13 - 11:51 am
Tags:
rheumatoid arthritis, AbbVie, Pfizer, Merck, JNJ, Amgen
AbbVie board OKs $1.5B for share buybacks
Yahoo/AP
Fri, 02/15/13 - 11:27 am
Tags:
AbbVie, share repurchase
The Meat and Potatoes of Abbott Labs
Motley Fool
Fri, 02/15/13 - 10:59 am
Tags:
Abbott Labs, AbbVie
Can Johnson & Johnson Hold Its Ground in the Multiple Myeloma Market?
Motley Fool
Wed, 02/13/13 - 10:16 am
Tags:
JNJ, Multiple Myeloma, Velcade, Celgene, Revlimid, AbbVie, ONYX Pharmaceuticals, Bristol-Myers Squibb
The Impending Spinoff of a Spinoff
Motley Fool
Thu, 02/7/13 - 11:01 am
Tags:
AbbVie, Pfizer, Zoetis, Abbott Labs, Covidien
UPDATE 4-AbbVie forecasts slower Humira growth
Reuters
Wed, 01/30/13 - 06:03 pm
Tags:
AbbVie, Humira

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.